SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Technology Officer, Darya Chudova, sold a total of 22,935 shares for approximately $2.42 million.
• Market Impact: The transaction is considered immaterial relative to Guardant Health's $12.26 billion market capitalization.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	Services-Medical Laboratories

Insider Information

Field	Value
Name	Darya Chudova
CIK	0001977179
Title/Position	Chief Technology Officer
Relationship	Officer

Transaction Details

This analysis aggregates two separate sale transactions by the same insider on the same day.

Field	Value
Form Type	4
Transaction Date	2025-12-08
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	22,935
Price Per Share	~$105.43 (Weighted Average)
Total Value	$2,417,980
Shares Owned After	66,943
Ownership Type	Direct & Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$2,417,980
% of Market Cap	0.02%
Shares Transacted	22,935
% of Shares Outstanding	Not Available
Post-Transaction Ownership	66,943 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $12.26 billion, a $2.42 million transaction is not considered significant, representing only 0.02% of the company's value. This is well below the 0.1% threshold for even moderate significance.
• Ownership Concentration: Data on total shares outstanding was not available, so the insider's ownership percentage cannot be calculated. The sale reduced the insider's holdings from 89,878 to 66,943 shares, a disposition of approximately 25.5% of her prior holdings.
• Transaction Significance: The sale's significance is low due to its small size relative to the company's market capitalization. While the sale represents a notable portion of the insider's personal holdings, it is unlikely to have a material impact on the market's perception of the stock.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction value is insignificant compared to the company's market cap. Such sales by executives are common for personal financial planning, diversification, or tax purposes and do not necessarily signal a change in outlook for the company.

Volume & Sentiment

• Expected Volume Impact: Minimal. The number of shares sold is unlikely to cause a noticeable impact on daily trading volume.
• Sentiment Indicator: Neutral. The market is unlikely to react to a sale of this size from a large-cap company.

Additional Context

Transaction Notes

• Special Circumstances: The filing includes two separate sale transactions: one direct sale of 9,271 shares and one indirect sale of 13,664 shares from the Chudova Family Trust. The filing also disclosed a non-economic transfer of 68,144 shares from direct ownership to the same trust.